N-Acetyl Epitalon, a synthetic peptide banned by the FDA in 2023, is tied to dubious claims of lifespan extension and telomere enhancement. Its research comes from a singular lab, lacking independent support or validation.
Mechanism
This peptide aims to activate telomerase, potentially lengthening telomeres and rejuvenating aged cells. It may also regulate melatonin from the pineal gland, influencing sleep and circadian rhythms. However, the intricacies of its action remain largely untested in human studies.
Research
The supposed benefits of N-Acetyl Epitalon are drawn from limited preclinical studies demonstrating in vitro telomerase activation and melatonin restoration. Nonetheless, all findings originate from one Russian lab, with no independent replication. The FDA's ban highlights serious safety concerns and an absence of well-controlled clinical trials, especially in human subjects.
Synergies
While there may be potential synergies with other longevity-promoting compounds, thorough validation is still needed. Ben IQ will analyze YOUR labs and goals to help determine optimal combinations.
Trade-Offs
N-Acetyl Epitalon offers intriguing theoretical benefits, but its speculative nature, regulatory challenges, and potential safety risks demand careful consideration. Tailored insights will depend on YOUR unique health data.